MLYS
Price
$14.32
Change
+$0.06 (+0.42%)
Updated
Jul 25 closing price
Capitalization
933.31M
14 days until earnings call
SXTP
Price
$1.31
Change
-$0.03 (-2.24%)
Updated
Jul 25 closing price
Capitalization
4.23M
16 days until earnings call
Interact to see
Advertisement

MLYS vs SXTP

Header iconMLYS vs SXTP Comparison
Open Charts MLYS vs SXTPBanner chart's image
Mineralys Therapeutics
Price$14.32
Change+$0.06 (+0.42%)
Volume$558.94K
Capitalization933.31M
60 Degrees Pharmaceuticals
Price$1.31
Change-$0.03 (-2.24%)
Volume$109.91K
Capitalization4.23M
MLYS vs SXTP Comparison Chart in %
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. SXTP commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Buy and SXTP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (MLYS: $14.32 vs. SXTP: $1.31)
Brand notoriety: MLYS and SXTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 74% vs. SXTP: 13%
Market capitalization -- MLYS: $933.31M vs. SXTP: $4.23M
MLYS [@Biotechnology] is valued at $933.31M. SXTP’s [@Biotechnology] market capitalization is $4.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 1 FA rating(s) are green whileSXTP’s FA Score has 1 green FA rating(s).

  • MLYS’s FA Score: 1 green, 4 red.
  • SXTP’s FA Score: 1 green, 4 red.
According to our system of comparison, MLYS is a better buy in the long-term than SXTP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 5 TA indicator(s) are bullish while SXTP’s TA Score has 4 bullish TA indicator(s).

  • MLYS’s TA Score: 5 bullish, 5 bearish.
  • SXTP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than SXTP.

Price Growth

MLYS (@Biotechnology) experienced а +0.63% price change this week, while SXTP (@Biotechnology) price change was -9.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.47%. For the same industry, the average monthly price growth was +22.83%, and the average quarterly price growth was +43.96%.

Reported Earning Dates

MLYS is expected to report earnings on Aug 11, 2025.

SXTP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+8.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($933M) has a higher market cap than SXTP($4.23M). MLYS YTD gains are higher at: 16.328 vs. SXTP (-79.690). SXTP has higher annual earnings (EBITDA): -10.19M vs. MLYS (-201.44M). MLYS has more cash in the bank: 343M vs. SXTP (3.45M). SXTP has higher revenues than MLYS: SXTP (665K) vs MLYS (0).
MLYSSXTPMLYS / SXTP
Capitalization933M4.23M22,078%
EBITDA-201.44M-10.19M1,976%
Gain YTD16.328-79.690-20%
P/E RatioN/AN/A-
Revenue0665K-
Total Cash343M3.45M9,936%
Total DebtN/A155K-
TECHNICAL ANALYSIS
Technical Analysis
MLYSSXTP
RSI
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 19 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOMGX35.210.58
+1.67%
Lord Abbett Growth Opportunities F3
HOOYX30.360.16
+0.53%
Hartford Schroders US Small Cap Opps Y
EIVAX14.650.07
+0.48%
Allspring Special Large Cap Value A
JEMSX35.99-0.07
-0.19%
JPMorgan Emerging Markets Equity I
JINTX34.53-0.13
-0.38%
Johnson International

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+0.42%
PTGX - MLYS
50%
Loosely correlated
+2.62%
BIESF - MLYS
45%
Loosely correlated
N/A
XERS - MLYS
39%
Loosely correlated
-2.90%
ACLX - MLYS
36%
Loosely correlated
+1.48%
APGE - MLYS
35%
Loosely correlated
-1.97%
More

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and VRAX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
-2.24%
VRAX - SXTP
25%
Poorly correlated
-4.42%
MLYS - SXTP
23%
Poorly correlated
+0.42%
ABCZF - SXTP
23%
Poorly correlated
N/A
XFOR - SXTP
23%
Poorly correlated
-0.55%
PASG - SXTP
23%
Poorly correlated
+29.84%
More